NCT03902184Phase 2Completed

IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

Study sponsor: Innate Pharma

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-01-08Actual
Enrollment · participants170Actual
Source updated2026-04-29Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Primary completion date changed

− Before

31 Oct 2023

+ After

8 Jan 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source